ChemicalBook > CAS DataBase List > 6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline

Product Name
6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline
CAS No.
1936429-80-9
Chemical Name
6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline
Synonyms
6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline;Quinoline, 6-bromo-7-(difluoromethyl)-1,2,3,4-tetrahydro-
CBNumber
CB68224822
Molecular Formula
C10H10BrF2N
Formula Weight
262.09
MOL File
1936429-80-9.mol
More
Less

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline Property

Boiling point:
328.6±42.0 °C(Predicted)
Density 
1.485±0.06 g/cm3(Predicted)
storage temp. 
Storage temp. 2-8°C
pka
3.60±0.20(Predicted)
Appearance
White to yellow Solid
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline Chemical Properties,Usage,Production

Uses

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline is an intermediate in the synthesis of GNE-781 (D447825), a derivative of a highly advanced, potent and selective bromodomain inhibitor of cyclic adenosine monophosphate response element binding protein (CBP). Inhibition of the bromodomain of the transcriptional regulator CBP/P300 is an especially interesting new therapeutic approach in oncology.

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline Suppliers

Taizhou Tongxin Bio-Tech Co., Ltd
Tel
0523-86818997 18652728585
Email
sales@allyrise.com
Country
China
ProdList
2975
Advantage
60
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Fax
+86-21-61629029
Email
product02@bidepharm.com
Country
China
ProdList
39999
Advantage
60
Chengdu Novel Biomedical Co., Ltd.
Tel
028-85255396 18302801538
Fax
028-85255396
Email
cdnovell@163.com
Country
China
ProdList
2405
Advantage
58
SHANGHAI FDC-CHEMICAL CO.,LTD
Tel
021-61469567 13482353728
Fax
021-61161605
Email
sales@fdc-chemical.com
Country
China
ProdList
9964
Advantage
58
Shandong utilizing biological technology co., LTD
Tel
15966937598
Fax
3407640895 3071519937
Email
3407650895@qq.com
Country
China
ProdList
4117
Advantage
58
Niuruisi Medical Technology Co. Ltd.
Tel
13872091715
Email
cheng1297@126.com
Country
China
ProdList
282
Advantage
58
Allfluoro pharmaceutical co. ltd.
Tel
+86-400-0216110 +86-15958047586
Fax
0086-21-33275002
Email
sales@allfluoro.com
Country
China
ProdList
11385
Advantage
58
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd.
Tel
15990591583
Fax
qq: 1050376806 mailbox : sales@nbpharmabridge.com
Country
China
ProdList
6108
Advantage
58
Wuhan chuang he chemical co. LTD
Tel
15907120073
Fax
15527109962
Email
1261789306@qq.com
Country
China
ProdList
1342
Advantage
58
Taizhou Nanfeng Pharmaceutical Research Institute
Tel
nanfengdrug@163.com; 18616377689
Email
nanfengdrug@163.com
Country
China
ProdList
20009
Advantage
58